ApicHope Pharmaceutical Co Ltd (300723)

Currency in CNY
72.07
-3.04(-4.05%)
Closed·
300723 Scorecard
Full Analysis
Net income is expected to grow this year
300723 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
71.9375.34
52 wk Range
12.7481.40
Key Statistics
Bid/Ask
72.11 / 72.07
Prev. Close
75.11
Open
74.66
Day's Range
71.93-75.34
52 wk Range
12.74-81.4
Volume
13.35M
Average Volume (3m)
13.44M
1-Year Change
287.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300723 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
40.26
Downside
-44.14%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

ApicHope Pharmaceutical Co Ltd Company Profile

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drop, montelukast sodium granule, acyclovir for injection, and oseltamivir phosphate capsule products. The company’s chronic disease drugs comprise hepatocyte growth stimulating hormone and pentoxifylline for injections, kangshen granules, uqingshu granules, shenbai lotion products, compound monoammonium glycyrrhizinate S and lansoprazole for injections, houttuynia sodium tablets, omeprazole sodium and bromhexine hydrochloride for injections, huixinkang tablets, amlodipine benzenesulfonate dispersible tablets, yanhunin and sodium ferulate for injections, cyclic adenosine phosphate and ambroxol hydrochloride for injections, valsartan amlodipine tablets, and nifedipine controlled release tablets, as well as tricorutin, aceglutamide, vinpocetine, and doxofylline for injections. In addition, it offers compound xiangrui water, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; venlafaxine hydrochloride sustained-release capsules; and levofloxacin hydrochloride, sodium ozagrel, brain protein hydrolysate, and ganciclovir for injections. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Guangzhou, China.

Employees
1484
Market
China

Compare 300723 to Peers and Sector

Metrics to compare
300723
Peers
Sector
Relationship
P/E Ratio
−55.4x−15.2x−0.5x
PEG Ratio
0.130.030.00
Price/Book
16.7x3.7x2.6x
Price / LTM Sales
26.9x4.8x3.2x
Upside (Analyst Target)
−44.1%−5.3%41.7%
Fair Value Upside
Unlock−9.4%6.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 40.26
(-44.14% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1.29%
Dividend Yield
-
Industry Median 1.53%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
376.96M / --
EPS Revisions
Last 90 days

300723 Income Statement

FAQ

What Stock Exchange Does ApicHope Pharmaceutical Trade On?

ApicHope Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for ApicHope Pharmaceutical?

The stock symbol for ApicHope Pharmaceutical is "300723."

What Is the ApicHope Pharmaceutical Market Cap?

As of today, ApicHope Pharmaceutical market cap is 32.36B.

What Is ApicHope Pharmaceutical's Earnings Per Share (TTM)?

The ApicHope Pharmaceutical EPS (TTM) is -1.29.

When Is the Next ApicHope Pharmaceutical Earnings Date?

ApicHope Pharmaceutical will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is 300723 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ApicHope Pharmaceutical Stock Split?

ApicHope Pharmaceutical has split 2 times.

How Many Employees Does ApicHope Pharmaceutical Have?

ApicHope Pharmaceutical has 1484 employees.

What is the current trading status of ApicHope Pharmaceutical (300723)?

As of 26 Jul 2025, ApicHope Pharmaceutical (300723) is trading at a price of 72.07, with a previous close of 75.11. The stock has fluctuated within a day range of 71.93 to 75.34, while its 52-week range spans from 12.74 to 81.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.